Stay updated on Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial
Sign up to get notified when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.

Latest updates to the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision entry labeled v3.6.6 was added to the page history, while the prior revision v3.6.5 was removed, reflecting an update to the page's versioning in the history list.SummaryDifference0.1%

- Check22 days agoChange DetectedThe record history now includes a new entry for 'Study Status'. The version count shows 36, indicating a recent status update has been logged in the study record.SummaryDifference0.3%

- Check36 days agoChange DetectedThe history now shows a new revision tag v3.6.5, replacing the previous v3.6.4.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page history now lists a new release tag v3.6.4. This indicates a software update to the site reflected in the record history.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page history now lists Revision: v3.6.3, replacing the previous v3.6.2.SummaryDifference0.1%

- Check79 days agoChange DetectedA new revision entry (v3.6.2) was added to the study record history, following the previous v3.6.0 entry. This documents an incremental update to the record on the ClinicalTrials.gov page.SummaryDifference0.1%

Stay in the know with updates to Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.